Mona Shing
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
-
- Brain Metastases and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 10
- Colorectal Cancer Treatments and Studies 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Cardiac tumors and thrombi 1
- Co-authors
- Adam Brufsky (1 shared paper)Musa Mayer (1 shared paper)Melissa G. Brammer (1 shared paper)Elizabeth Tan-Chiu (1 shared paper)Lisa I. Wang (1 shared paper)Peter Andrew Kaufman (1 shared paper)Debu Tripathy (1 shared paper)Hope S. Rugo (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Breast Cancer Research and Treatment (2 papers)Clinical Colorectal Cancer (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Mona Shing
18 papers receiving 932 citations
Peers
Comparison fields: 5 of 60
- Oncology 332
- Pulmonary and Respiratory Medicine 311
- Neurology 72
- Genetics 49
- Biomaterials 67
Countries citing papers authored by Mona Shing
This map shows the geographic impact of Mona Shing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Shing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Shing more than expected).
Fields of papers citing papers by Mona Shing
This network shows the impact of papers produced by Mona Shing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Shing. The network helps show where Mona Shing may publish in the future.
Co-authors
The 25 scholars most cited alongside Mona Shing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 321 | |
| 2 | 2013 | 164 | |
| 3 | 2017 | 104 | |
| 4 | 2013 | 72 | |
| 5 | 2016 | 67 | |
| 6 | 2015 | 45 | |
| 7 | 2017 | 44 | |
| 8 | 2018 | 36 | |
| 9 | 2009 | 27 | |
| 10 | 2007 | 23 | |
| 11 | 2018 | 23 | |
| 12 | 2018 | 12 | |
| 13 | 2001 | 11 | |
| 14 | Phase III study (20050181) of panitumumab with FOLFIRI compared to FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer: preliminary safety results. | 2008 | 7 |
| 15 | 2017 | 2 | |
| 16 | 2015 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 0 |
About Mona Shing
Mona Shing is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Genetics, Pulmonary and Respiratory Medicine and Neurology, having authored 19 papers that have together received 961 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Brain Metastases and Treatment (1 paper), Cardiac tumors and thrombi (1 paper), Glioma Diagnosis and Treatment (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper) and Multiple Sclerosis Research Studies (1 paper). The work is most often cited by research in Oncology (332 citations), Pulmonary and Respiratory Medicine (311 citations), Neurology (72 citations), Genetics (49 citations) and Biomaterials (67 citations). Mona Shing has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Adam Brufsky, Musa Mayer, Melissa G. Brammer, Elizabeth Tan-Chiu, Lisa I. Wang, Peter Andrew Kaufman, Debu Tripathy, Hope S. Rugo, Iulia Cristina Tudor and Denise Aysel Yardley. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Clinical Cancer Research, Breast Cancer Research and Treatment and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.